Mackenzie Financial’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $329K | Sell |
18,079
-50,594
| -74% | -$921K | ﹤0.01% | 1361 |
|
|
2025
Q1 | $1.36M | Sell |
68,673
-5,866
| -8% | -$116K | ﹤0.01% | 892 |
|
|
2024
Q4 | $1.28M | Buy |
74,539
+50,660
| +212% | +$869K | ﹤0.01% | 884 |
|
|
2024
Q3 | $477K | Buy |
23,879
+1,190
| +5% | +$23.8K | ﹤0.01% | 1034 |
|
|
2024
Q2 | $254K | Buy |
22,689
+507
| +2% | +$5.67K | ﹤0.01% | 1244 |
|
|
2024
Q1 | $146K | Buy |
22,182
+1,380
| +7% | +$9.11K | ﹤0.01% | 1386 |
|
|
2023
Q4 | $94K | Hold |
20,802
| – | – | ﹤0.01% | 1415 |
|
|
2023
Q3 | $69.3K | Hold |
20,802
| – | – | ﹤0.01% | 1383 |
|
|
2023
Q2 | $76.3K | Buy |
20,802
+8,567
| +70% | +$31.4K | ﹤0.01% | 1426 |
|
|
2023
Q1 | $40.5K | Buy |
12,235
+700
| +6% | +$2.32K | ﹤0.01% | 1452 |
|
|
2022
Q4 | $44.8K | Sell |
11,535
-700
| -6% | -$2.72K | ﹤0.01% | 1356 |
|
|
2022
Q3 | $30K | Sell |
12,235
-518
| -4% | -$1.27K | ﹤0.01% | 1390 |
|
|
2022
Q2 | $258K | Buy |
+12,753
| New | +$258K | ﹤0.01% | 1160 |
|